Fate Therapeutics
FATE
#8278
Rank
HK$2.39 B
Marketcap
HK$20.58
Share price
-7.24%
Change (1 day)
127.98%
Change (1 year)

Earnings for Fate Therapeutics (FATE)

Earnings in 2026 (TTM): -HK$1.09 Billion

According to Fate Therapeutics 's latest financial reports the company's current earnings are HK$6.31 Million. In 2025 the company made an earning of -HK$1.16 Billion, an increase over its 2024 earnings that were of -HK$1.54 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Fate Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1.09 Billion-5.93%
2025 -HK$1.16 Billion-24.46%
2024 -HK$1.54 Billion2.64%
2023 -HK$1.5 Billion-38.22%
2022 -HK$2.42 Billion45.36%
2021 -HK$1.67 Billion43.54%
2020 -HK$1.16 Billion53.32%
2019 -HK$0.76 Billion48.53%
2018 -HK$0.51 Billion55.7%
2017 -HK$0.33 Billion30.98%
2016 -HK$0.25 Billion14.59%
2015 -HK$0.22 Billion9.62%
2014 -HK$0.2 Billion14.83%
2013 -HK$0.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
HK$12.89 B-1,279.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$0.19 B-117.55%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-HK$1.85 Billion 69.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$6.26 B-672.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-HK$5.37 Billion 391.04%๐Ÿ‡บ๐Ÿ‡ธ USA